✦ LIBER ✦

Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology

✍ Scribed by German A. Gomez; Maurice Barcos; Tin Han; Edward S. Henderson

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 702 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870701)60:1<18::aid-cncr2820600105>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with cyclophosp

Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas. A report of 131 cases

✍ Yolaine Parlier; Norbert Claude Gorin; Albert Najman; Jerzy Stachowiak; Gerard D 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Activity and safety of dose-adjusted inf

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco; Giovanna Vasini; Stefan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Activity and safety of dose-adjusted inf

✍ Alberto Febbri; Alessandro Gozzetti; Luigi Rigacci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

A randomized comparison of methotrexate

A randomized comparison of methotrexate dose and the addition of bleomycin to chop therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas cancer and leukemia group B study 7851

✍ Arlan J. Gottlieb; James R. Anderson; Sandra J. Ginsberg; Clara D. Bloomfield; L 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 771 KB

Reply to activity and safety of dose-adj

Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views